about
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity.Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma.Synthesis and biological evaluation of phenstatin metabolites.Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.PD-1/PD-L1 binding studies using microscale thermophoresis.Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface.Colonization of Mice byCandida albicansIs Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3Isolation and characterization of two canine melanoma cell lines: new models for comparative oncologyCannabis : des nouvelles fonctions anti-diarrhéiques et anti-cancéreusesEnhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligandsMUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale ThermophoresisChemical reactivity and uses of 1-phenyl-3-methyl-5-pyrazolone (PMP), also known as edaravoneExploring isoxazoles and pyrrolidinones decorated with the 4,6-dimethoxy-1,3,5-triazine unit as human farnesyltransferase inhibitors
P50
Q35760524-3E4D0B44-7934-444F-81C6-AB0013B3FFDCQ36014007-4F6581DF-5FB7-4C7B-A2AC-8B1AA0A1C9FAQ38751222-DAC0E03A-0079-4CB3-B010-D1177705B280Q38853518-2F72185A-BBF1-42C2-8CEA-6B1AC1449D21Q39473253-CBC48DE9-5D1F-4127-9FDB-C1381A1187ADQ44333170-9E6D4175-4665-4912-89A2-A93528FEC8E5Q47109966-C738F95D-27B5-45EF-AD4B-01B34B432748Q55261227-BF772BE7-5817-4694-8216-4EAF0BA86B88Q56019292-4A9DEA4B-0E48-4A12-A72D-1DE43C450F7DQ59793078-BF2F25B2-FE47-4170-A730-83E572FFB099Q62660187-01412426-318D-4DE3-9723-118717CD02D0Q89607513-E031DB88-FAE8-4B43-AE9C-AA95408754F9Q91272239-974803F4-7543-43B5-B548-265741EA2AF0Q91518685-69BCB30C-D571-4086-8850-80DD2154CCE6Q92853027-07EF5792-5A9B-4D4C-AED0-5CCA6141CDCA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Xavier Thuru
@ast
Xavier Thuru
@en
Xavier Thuru
@es
Xavier Thuru
@nl
type
label
Xavier Thuru
@ast
Xavier Thuru
@en
Xavier Thuru
@es
Xavier Thuru
@nl
prefLabel
Xavier Thuru
@ast
Xavier Thuru
@en
Xavier Thuru
@es
Xavier Thuru
@nl
P106
P1153
16680031300
P21
P31
P496
0000-0002-0998-4160